csl300
Showing 1 - 1 of 1
Atherosclerotic Cardiovascular Disease, End Stage Kidney Disease Trial (CSL300, Placebo)
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- End Stage Kidney Disease
- CSL300
- Placebo
- (no location specified)
Aug 1, 2022